Potential therapeutic target for prostate cancers with PTEN mutation September 24, 2019 adminMeds newsNo Comment on Potential therapeutic target for prostate cancers with PTEN mutation PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function.